IMI becomes IHI
Conscious that future breakthroughs in healthcare and medical science will be the result of cross-sectorial discoveries, IMI needed to evolve. Europe is at a crossroads, facing increasing challenges on several fronts while at the same time, technological and scientific advances offer new opportunities to solve these challenges. Bridging the gap to address today's health and translational challenges will require a multi-sector public-private partnership.
The successes of IMI and the knowledge gleaned from 14 years of experience and almost 200 projects means that IHI will ensure Europe remains at the cutting edge of interdisciplinary, sustainable, patient-centric health research.
- Pioneer the patient-centred integration of knowledge, technology and products
- Tackle each and every aspect of care to improve lives of patients across Europe and beyond
- Strengthen Europe’s position at the forefront of medical innovation
- Address current and future health challenges
EFPIA members committed nearly 3 billion Euros across IMI1, IMI2 and IHI to progress biomedical research and address patients and societal needs.
How can this Partnership help solve significant current and future health challenges in different healthcare areas?
If you have any questions, please contact the Science Policy team at email@example.com
Landmark moment for Innovative Health Initiative (IHI)IHI’s first calls for proposals present an unprecedented opportunity to tackle key EU priorities and unmet medical need in a new way28.06.22Read Article
The Innovative Health Initiative (IHI) will carry IMI torchToday we celebrate the launch of the Innovative Health Initiative, the future “home” of both ongoing IMI and future IHI projects.26.01.22Read Article
Industry partners welcome adoption of Innovative Health InitiativeThe Innovative Health Initiative is a unique cross-sectoral initiative aiming at strengthening Europe’s position at the forefront of health innovation.19.11.21Read Article
A strategic research & innovation agenda for a healthier EuropeA joint statement from COCIR, EFPIA, MedTech Europe, EuropaBio and Vaccines Europe21.06.21Read Article